Epidemiology, development and treatment of end-stage renal failure in Type 2 (non-insulin-dependent) diabetes mellitus

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Diabetologia

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02374507PMID 8243863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of handicap in chronic dialysis diabetic patients (Uremidiab section study).

  1992cited by this paper
• Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study).

  1992cited by this paper
• Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients.

  1992cited by this paper
• Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide.

  1992cited by this paper
• The United States Renal Data System's 1991 annual data report: an introduction.

  1991cited by this paper
• La population des DOM en 1990

  1991cited by this paper
• Type II diabetes mellitus: is the renal risk adequately appreciated?

  1991cited by this paper
• Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987.

  1990cited by this paper
• Diabetes mellitus and renal replacement therapy in Italy: prevalence, main characteristics and complications.

  1990cited by this paper
• Dialysis treatment in Australia, 1982 to 1988.

  1990cited by this paper
• Mortality in chronic dialysis patients in Japan.

  1990cited by this paper
• Renal function in black Americans with type II diabetes.

  1989cited by this paper
• Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population.

  1989cited by this paper
• Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.

  1989cited by this paper
• [Metabolic management of terminal kidney insufficiency in diabetics].

  1989cited by this paper
• Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.

  1988influential reference
• Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction.

  1988cited by this paper
• Incidence of end-stage renal disease in Type 2 (non-insulin-dependent) diabetes mellitus in pima indians

  1988cited by this paper
• Predictors of survival in patients undergoing dialysis.

  1988cited by this paper
• Excess incidence of treatment of end-stage renal disease in Mexican Americans.

  1988cited by this paper
• Non‐insulin‐dependent Diabetes and Renal Replacement Therapy

  1988cited by this paper
• Comparative renal pathophysiology relevant to IDDM and NIDDM patients.

  1988cited by this paper
• The high prevalence of diabetes mellitus, impaired glucose tolerance and diabetic retinopathy in Nauru--the 1982 survey.

  1984cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper

• Prevalence and characteristics of diabetic kidney disease in type 2 diabetic patients in Abidjan, Côte d’Ivoire

  2018cites this paper
• End stage renal disease in French Guiana (data from R.E.I.N registry): South American or French?

  2017cites this paper
• Néphropathie diabétique: macroalbuminurie, insuffisance rénale

  2017cites this paper
• Maladies rénales liées aux diabètes : épidémiologie et coûts

  2011cites this paper
• [Diabetes and chronic kidney disease: lessons from renal epidemiology].

  2010influential citation
• An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

  2005cites this paper
• [Inequalities to the access of renal transplantation for French patients living in the overseas French territories].

  2004cites this paper
• Anthropometric parameters and type 2 diabetes: a case-control study in a Guadeloupean population.

  2004cites this paper
• What is the impact of PRIME on real‐life diabetic nephropathy?

  2004cites this paper
• Angiotensin‐I‐converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients

  2003cites this paper
• Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.

  2001cites this paper
• Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.

  2001cites this paper
• Role of mesangial expansion in the pathogenesis of diabetic nephropathy.

  2001cites this paper
• Diabetes mellitus in Tassin, France: remarkable transformation in incidence and outcome of ESRD in diabetes.

  2001cites this paper
• The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

  2000cites this paper
• Structural involvement in type 1 and type 2 diabetic nephropathy.

  2000cites this paper
• Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.

  2000cites this paper
• Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet.

  2000cites this paper
• End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

  1999cites this paper
• Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study).

  1999cites this paper
• Abysmal prognosis of patients with type 2 diabetes entering dialysis.

  1999cites this paper
• Renal disease and hypertension in non-insulin-dependent diabetes mellitus.

  1999cites this paper
• Short-term outcome of diabetic patients in renal replacement therapy.

  1998cites this paper
• Fatty acid composition of phospholipids and neutral lipids from human diabetic small arteries and veins by a new TLC method.

  1998cites this paper
• Methods of literature review and synthesis.

  1998cites this paper
• Erythropoietin can deteriorate glucose control in uraemic non-insulin-dependent diabetic patients.

  1998cites this paper
• Renal structural changes in non-insulin-dependent diabetes mellitus.

  1997cites this paper
• Diabetic nephropathy in type II diabetes.

  1996cites this paper
• [Nephropathy in non-insulin-dependent diabetics].

  1996cites this paper
• Diabetic patients on renal replacement therapy.

  1996cites this paper
• [An epidemiologic approach for the prevention of renal insufficiency].

  1996cites this paper
• Patterns of renal injury in NIDDM patients with microalbuminuria

  1996cites this paper
• Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM

  1996cites this paper
• [Arterial hypertension and diabetes. Members of the Board of Directors and Scientific Directors of ALFEDIAM].

  1996cites this paper
• An Economic Analysis of Captopril in the Treatment of Diabetic Nephropathy

  1996cites this paper
• [Diabetes, dialysis, health costs].

  1996cites this paper
• The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis.

  1995cites this paper
• The rising tide of diabetic nephropathy--the warning before the flood?

  1995cites this paper